Literature DB >> 29376889

BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease.

Evelyn Ullrich1,2,3, Benjamin Abendroth4, Johanna Rothamer1,2,3, Carina Huber4, Maike Büttner-Herold5, Vera Buchele4, Tina Vogler4, Thomas Longerich6, Sebastian Zundler4, Simon Völkl1, Andreas Beilhack7, Stefan Rose-John8, Stefan Wirtz4, Georg F Weber9, Sakhila Ghimire10, Marina Kreutz10, Ernst Holler10, Andreas Mackensen1, Markus F Neurath4, Kai Hildner4.   

Abstract

Acute graft-versus-host disease (GVHD) represents a severe, T cell-driven inflammatory complication following allogeneic hematopoietic cell transplantation (allo-HCT). GVHD often affects the intestine and is associated with a poor prognosis. Although frequently detectable, proinflammatory mechanisms exerted by intestinal tissue-infiltrating Th cell subsets remain to be fully elucidated. Here, we show that the Th17-defining transcription factor basic leucine zipper transcription factor ATF-like (BATF) was strongly regulated across human and mouse intestinal GVHD tissues. Studies in complete MHC-mismatched and minor histocompatibility-mismatched (miHA-mismatched) GVHD models revealed that BATF-expressing T cells were functionally indispensable for intestinal GVHD manifestation. Mechanistically, BATF controlled the formation of colon-infiltrating, IL-7 receptor-positive (IL-7R+), granulocyte-macrophage colony-stimulating factor-positive (GM-CSF+), donor T effector memory (Tem) cells. This T cell subset was sufficient to promote intestinal GVHD, while its occurrence was largely dependent on T cell-intrinsic BATF expression, required IL-7-IL-7R interaction, and was enhanced by GM-CSF. Thus, this study identifies BATF-dependent pathogenic GM-CSF+ effector T cells as critical promoters of intestinal inflammation in GVHD and hence putatively provides mechanistic insight into inflammatory processes previously assumed to be selectively Th17 driven.

Entities:  

Keywords:  Bone marrow transplantation; Cytokines; Gastroenterology; Immunology; T cells

Mesh:

Substances:

Year:  2018        PMID: 29376889      PMCID: PMC5824870          DOI: 10.1172/JCI89242

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  High resolution colonoscopy in live mice.

Authors:  C Becker; M C Fantini; M F Neurath
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

2.  Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.

Authors:  Miguel-Angel Perales; Jenna D Goldberg; Jianda Yuan; Guenther Koehne; Lauren Lechner; Esperanza B Papadopoulos; James W Young; Ann A Jakubowski; Bushra Zaidi; Humilidad Gallardo; Cailian Liu; Teresa Rasalan; Jedd D Wolchok; Therese Croughs; Michel Morre; Sean M Devlin; Marcel R M van den Brink
Journal:  Blood       Date:  2012-09-25       Impact factor: 22.113

3.  Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse.

Authors:  S Thiant; I Yakoub-Agha; L Magro; J Trauet; V Coiteux; J-P Jouet; J-P Dessaint; M Labalette
Journal:  Bone Marrow Transplant       Date:  2010-03-01       Impact factor: 5.483

4.  IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells.

Authors:  Rebecca Noster; René Riedel; Mir-Farzin Mashreghi; Helena Radbruch; Lutz Harms; Claudia Haftmann; Hyun-Dong Chang; Andreas Radbruch; Christina E Zielinski
Journal:  Sci Transl Med       Date:  2014-06-18       Impact factor: 17.956

5.  Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects.

Authors:  Kathrin Meinhardt; Irena Kroeger; Ruth Bauer; Franziska Ganss; Ilja Ovsiy; Johanna Rothamer; Maike Büttner; Imke Atreya; Maximilian Waldner; Max Bittrich; Christian Hk Lehmann; Michael A Rieger; Andreas Beilhack; Robert Zeiser; Matthias Edinger; Diana Dudziak; Andreas Mackensen; Michael Rehli; Evelyn Ullrich
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

6.  Caspase-8 controls the gut response to microbial challenges by Tnf-α-dependent and independent pathways.

Authors:  Claudia Günther; Barbara Buchen; Gui-Wei He; Mathias Hornef; Natalia Torow; Helmut Neumann; Nadine Wittkopf; Eva Martini; Marijana Basic; André Bleich; Alastair J M Watson; Markus F Neurath; Christoph Becker
Journal:  Gut       Date:  2014-06-24       Impact factor: 23.059

7.  Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma.

Authors:  Takeya Adachi; Tetsuro Kobayashi; Eiji Sugihara; Taketo Yamada; Koichi Ikuta; Stefania Pittaluga; Hideyuki Saya; Masayuki Amagai; Keisuke Nagao
Journal:  Nat Med       Date:  2015-10-19       Impact factor: 53.440

8.  Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.

Authors:  David R Withers; Matthew R Hepworth; Xinxin Wang; Emma C Mackley; Emily E Halford; Emma E Dutton; Clare L Marriott; Verena Brucklacher-Waldert; Marc Veldhoen; Judith Kelsen; Robert N Baldassano; Gregory F Sonnenberg
Journal:  Nat Med       Date:  2016-02-15       Impact factor: 53.440

9.  BATF is required for normal expression of gut-homing receptors by T helper cells in response to retinoic acid.

Authors:  Chuanwu Wang; Shankar Thangamani; Myunghoo Kim; Bon-Hee Gu; Jee H Lee; Elizabeth J Taparowsky; Chang H Kim
Journal:  J Exp Med       Date:  2013-03-04       Impact factor: 14.307

10.  GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival.

Authors:  Ivo Sonderegger; Giandomenica Iezzi; Reinhard Maier; Nicole Schmitz; Michael Kurrer; Manfred Kopf
Journal:  J Exp Med       Date:  2008-09-08       Impact factor: 14.307

View more
  17 in total

1.  Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care.

Authors:  Olle Ringdén; Mats Remberger; Johan Törlén; Sigrun Finnbogadottir; Britt-Marie Svahn; Behnam Sadeghi
Journal:  Int J Hematol       Date:  2021-02-05       Impact factor: 2.490

2.  ST2/MyD88 Deficiency Protects Mice against Acute Graft-versus-Host Disease and Spares Regulatory T Cells.

Authors:  Brad Griesenauer; Hua Jiang; Jinfeng Yang; Jilu Zhang; Abdulraouf M Ramadan; Jane Egbosiuba; Khaled Campa; Sophie Paczesny
Journal:  J Immunol       Date:  2019-04-12       Impact factor: 5.422

Review 3.  Transcription Factor Bhlhe40 in Immunity and Autoimmunity.

Authors:  Melissa E Cook; Nicholas N Jarjour; Chih-Chung Lin; Brian T Edelson
Journal:  Trends Immunol       Date:  2020-10-07       Impact factor: 16.687

4.  RUNX inhibitor suppresses graft-versus-host disease through targeting RUNX-NFATC2 axis.

Authors:  Hirohito Kubota; Tatsuya Masuda; Mina Noura; Kana Furuichi; Hidemasa Matsuo; Masahiro Hirata; Tatsuki R Kataoka; Hidefumi Hiramatsu; Takahiro Yasumi; Tatsutoshi Nakahata; Yoichi Imai; Junko Takita; Souichi Adachi; Hiroshi Sugiyama; Yasuhiko Kamikubo
Journal:  EJHaem       Date:  2021-05-19

5.  Newly found arsons ignite the fire of gut GVHD.

Authors:  Defu Zeng
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

6.  Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance induction.

Authors:  Yuanyuan Tian; Lijun Meng; Ying Wang; Bohan Li; Hongshuang Yu; Yan Zhou; Tien Bui; Ciril Abraham; Alicia Li; Yongping Zhang; Jian Wang; Chenchen Zhao; Shin Mineishi; Stefania Gallucci; David Porter; Elizabeth Hexner; Hong Zheng; Yanyun Zhang; Shaoyan Hu; Yi Zhang
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

7.  Donor T-cell-derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract.

Authors:  Kate H Gartlan; Motoko Koyama; Katie E Lineburg; Karshing Chang; Kathleen S Ensbey; Rachel D Kuns; Andrea S Henden; Luke D Samson; Andrew D Clouston; Angel F Lopez; Kelli P A MacDonald; Geoffrey R Hill
Journal:  Blood Adv       Date:  2019-10-08

Review 8.  Resolution of acute intestinal graft-versus-host disease.

Authors:  Sindhu Thiagarajan; Markus F Neurath; Kai Hildner
Journal:  Semin Immunopathol       Date:  2019-10-31       Impact factor: 9.623

9.  Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.

Authors:  Clint Piper; Vivian Zhou; Richard Komorowski; Aniko Szabo; Benjamin Vincent; Jonathan Serody; Maria-Luisa Alegre; Brian T Edelson; Reshma Taneja; William R Drobyski
Journal:  Blood       Date:  2020-02-20       Impact factor: 22.113

10.  Targeting Inflammatory T Helper Cells via Retinoic Acid-Related Orphan Receptor Gamma t Is Ineffective to Prevent Allo-Response-Driven Colitis.

Authors:  Vera Buchele; Benjamin Abendroth; Maike Büttner-Herold; Tina Vogler; Johanna Rothamer; Sakhila Ghimire; Evelyn Ullrich; Ernst Holler; Markus F Neurath; Kai Hildner
Journal:  Front Immunol       Date:  2018-05-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.